AVM v1, released 02-OCT-22

A manually curated database of aerosol-transmitted virus mutations, human diseases, and drugs

Mutation detail:


Mutation site K229R
Virus Influenzavirus A H1N1
Mutation level Amino acid Level
Gene/protein/region type PB1
Gene ID 23308122
Country -
Mutation type nonsynonymous mutation
Genotype/subtype/clade -
Sample cell line
Variants -
Viral reference sequence GQ166655.1
Drug/antibody/vaccine favipiravir resistant
Transmissibility promote
Transmission mechanism -
Pathogenicity -
Pathogenicity mechanism -
Immune escape mutation -
Immune escape mechanism -
RT-PCR primers probes -

Protein detail:


Protein name Polymerase PB1
Uniprot protein ID C3W5X7
Protein length 757 amino acids
Protein description RNA-dependent RNA polymerase which is responsible for replication and transcription of virus RNA segments. The transcription of viral mRNAs occurs by a unique mechanism called cap-snatching. 5' methylated caps of cellular mRNAs are cleaved after 10-13 nucleotides by PA. In turn, these short capped RNAs are used as primers by PB1 for transcription of viral mRNAs. During virus replication, PB1 initiates RNA synthesis and copy vRNA into complementary RNA (cRNA) which in turn serves as a template for the production of more vRNAs

Literature information:


Pubmed ID 34061908
Clinical information No
Disease -
Published year 2021
Journal PLoS Pathog
Title Favipiravir-resistant influenza A virus shows potential for transmission
Author Daniel H Goldhill,Ada Yan,Rebecca Frise,Jie Zhou,Jennifer Shelley
Evidence Modelling revealed that due to a fitness advantage for the PA P653L mutant, reassortment with the wild-type virus to gain wild-type PB1 segment in vivo resulted in the loss of the PB1 resistance mutation K229R.